低剂量纳尔特雷克松是否有效治疗慢性疼痛?
Roxanne Radi1, Harriet Huang1, Jason Rivera1
1University of Colorado Family Medicine Residency, Denver.
The Journal of family practice
|September 20, 2023
概括
低剂量纳尔特雷克松有效治疗疼痛的糖尿病神经病变,匹配阿米林.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 疼痛性糖尿病神经病变是一种糖尿病的常见并发症.
- 目前的治疗方法在有效性和安全性方面存在局限性.
研究的目的:
- 评估低剂量纳尔特雷 (LDN) 对疼痛性糖尿病神经病变的疗效和安全性.
- 为了比较LDN与标准治疗方法阿米特利普提林.
主要方法:
- 一个单一的随机对照试验 (RCT) 将LDN与阿米林进行了比较.
- 一项回顾性队列研究评估了炎症和神经病痛的LDN.
- 一项前性剂量反应研究评估了纤维肌痛患者的LDN.
主要成果:
- 在治疗疼痛性糖尿病神经病变 (SOR,B) 方面,LDN的疗效与阿米西林相当.
- 在炎症性疾病中,LDN显著减少了32%,在神经病变 (SOR,B) 中减少了44%.
- 低剂量的LDN (5.4毫克) 在95%的纤维肌痛患者 (SOR,B) 中减少了疼痛.
结论:
- 低剂量纳尔特雷克松是一种可行的,更安全的替代方案,用于管理疼痛的糖尿病神经病变.
- 在包括纤维肌痛在内的各种慢性疼痛疾病中,LDN显示显著减少疼痛.
相关概念视频
Analgesia and Pain Management
652
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
652
Opioid Analgesics: Synthetic and Semisynthetic Opioids
331
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
331
Nociception
28.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.0K
Opioid Analgesics: Morphine and Other Natural Cogeners
286
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
286
CNS Depressants: Alcohol and Nicotine
241
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
241
Drugs for Treatment of Diarrhea-Predominant IBS
204
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
204


